Correction: -- XORTX Therapeutics Brief: Naming Dr. Michael Bumby, a Biotech/pharma Industry Veteran, as Its Chief Financial Officer Replacing James Fairbairn
Correction: -- XORTX Therapeutics Brief: Naming Dr. Michael Bumby, a Biotech/pharma Industry Veteran, as Its Chief Financial Officer Replacing James Fairbairn
更正：-- XORTX治疗公司简报：任命生物技术/制药行业资深人士迈克尔·邦比博士为首席财务官，接替詹姆斯·费尔贝恩。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间